UPCOMING DEADLINE: Lundin Law PC Announces Securities Class

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
141
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Snap Inc. and Reminds Investors with Losses Exceeding $500,000 to Contact the Firm

LOS ANGELES, July 03, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP ) regarding possible violations of federal securities laws. Investors who purchased or otherwise acquired Snap shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about March 2, 2017; and/or (2) on the open market from March 2, 2017 through May 15, 2017 inclusive (the “Class Period”), should contact the firm prior to the July 17, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here .

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com .

No class has been certified in the above action yet, and until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, during the Class Period, Snap made false and/or misleading statements, and/or failed to disclose, that the Company’s reported user growth was materially false and misleading.

On May 10, 2017, after-market hours, Snap revealed its first quarterly report as a public company, revealing disappointing user growth as well as a net loss of $2.2 billion. The user growth was the slowest year-to-year growth rate in at least two years. When this information was disclosed, Snap’s stock price fell materially, which caused investors harm. On May 16, 2017, Bloomberg reported that a former Snap employee, Anthony Pompliano, filed a lawsuit against the Company claiming that he was terminated for raising questions about the allegedly false growth metrics and that he was seeking whistleblower protection from retaliation by Snap.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.

Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 brian@lundinlawpc.com http://lundinlawpc.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading